ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Policy: NCAB Recommends Mammograms Every 1 to 2 Years for Average Risk Women 40-49

April 4, 1997

ACS, SU2C Committ $20 Million For Lung Cancer Dream Team

January 31, 2014

Jury Awards $14 Million To Medenica Patient

February 24, 1995

ONS Accredited As Approver, Provider Of Continuing Education

April 22, 1988

NCI Says Review Group Will Read Blueprint, Evaluate NCI Research

January 16, 1998

Letters to the Editor: Us Too! Objects to ODAC Member’s Comments; Brawley Responds

March 28, 2003